- Therapeutic role of miR-26a on cardiaorenal injury in mice model of angiotensin-II induced chronic kidney disease through inhibition of LIMS1/ILK pathway
Weijie Ni et al, 2024, Chinese Medical Journal CrossRef - Genetically engineered loaded extracellular vesicles for drug delivery
Zuriñe Erana-Perez et al, 2024, Trends in Pharmacological Sciences CrossRef - Fibrosis in Chronic Kidney Disease: Pathophysiology and Therapeutic Targets
Allison B. Reiss et al, 2024, Journal of Clinical Medicine CrossRef - MicroRNA‐26a alleviates tubulointerstitial fibrosis in diabetic kidney disease by targeting PAR4
Gaoting Qu et al, 2024, Journal of Cellular and Molecular Medicine CrossRef - Pharmacokinetic–pharmacodynamic modeling of the active components of Shenkang injection in rats with chronic renal failure and its protective effect on damaged renal cells
Lin Zhou et al, 2023, Biopharmaceutics & Drug Disposition CrossRef